EUVIMEDEUVIMED entdecken
Crossref

Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ

Rie Matsushima-Nishiwaki, Haruhiko Tokuda, Osamu Kozawa

Biochemical and Biophysical Research Communications · 2026-08 · 826 · 154014

DOI: 10.1016/j.bbrc.2026.154014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-08. Verfasst von Rie Matsushima-Nishiwaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan. Electronic address: nishiwaki.rie.r7@f.gifu-u.ac.jp. Hauptthemen laut MEDLINE: Cell Movement, Carcinoma, Hepatocellular, Liver Neoplasms, PPAR gamma. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and remains a public health problem with high mortality. We have previously reported that activation of cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) suppresses transforming growth factor (TGF)-α-induced migration of HCC cells. In the present study, we investigated whether cilostazol, a phosphodiesterase (PDE) inhibitor, affects the TGF-α-induced migration of HCC cells. Cilostazol significantly inhibited TGF-α-induced migration of human-derived HCC cells, HuH7. Dipyridamole, another PDE inhibitor, also significantly suppressed the cell migration induced by TGF-α. However, neither cilostazol nor dipyridamole increased the intracellular concentrations of cAMP under TGF-α-stimulation. Furthermore, TGF-α-induced HCC cell migration, which was inhibited by cilostazol and dipyridamole, was not affected by a PKA inhibitor. On the other hand, cilostazol and dipyridamole stimulated the activation of peroxisome proliferator-activated receptor γ (PPARγ) in HuH7 cells. We also found that PPARγ activators, ciglitazone and pioglitazone, significantly inhibited the TGF-α-induced migration of HuH7 cells. The inhibitory effects of cilostazol and dipyridamole on the migration of HuH7 cells were blocked by GW9662, an inhibitor of PPARγ. We have shown that AKT is involved in the TGF-α-induced HuH7 cell migration. The PPARγ activators reduced the TGF-α-induced AKT activation without affecting the EGFR activation. Cilostazol and dipyridamole also inhibited the activation of AKT but not EGFR. Taken together, these results strongly suggest that cilostazol and dipyridamole inhibit TGF-α-induced HCC cell migration by suppressing the AKT pathway through PPARγ activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementCarcinoma, HepatocellularLiver NeoplasmsPPAR gammaTransforming Growth Factor alphaTetrazolesHumansCilostazolCell Line, TumorDipyridamoleCyclic AMPPhosphodiesterase Inhibitors

Stichwörter der Autor:innen

AKTCilostazolHCCMigrationPPARγTGF-α

Substanzen

CilostazolPPAR gammaTransforming Growth Factor alphaTetrazolesDipyridamoleCyclic AMPPhosphodiesterase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan. Electronic address: nishiwaki.rie.r7@f.gifu-u.ac.jp.
  • Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu, 474-8511, Japan; Department of Clinical Laboratory, National Center for Geriatrics and Gerontology, Obu, 474-851…
  • Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, 501-1194, Japan.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science

Zitieren

APA

Matsushima-Nishiwaki, R., Tokuda, H., & Kozawa, O. (2026). Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ. Biochemical and Biophysical Research Communications, 826, 154014. https://doi.org/10.1016/j.bbrc.2026.154014

Vancouver

Matsushima-Nishiwaki R, Tokuda H, Kozawa O. Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ. Biochemical and Biophysical Research Communications. 2026;826:154014. doi:10.1016/j.bbrc.2026.154014

BibTeX
@article{MatsushimaNishiwaki2026,
  author = {Matsushima-Nishiwaki, Rie and Tokuda, Haruhiko and Kozawa, Osamu},
  title = {Cilostazol inhibits TGF-α-induced migration of hepatocellular carcinoma cells by activating PPARγ},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {826},
  pages = {154014},
  doi = {10.1016/j.bbrc.2026.154014}
}
Kostenlos starten →